Eric Huttenlocher Bent, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Microenvironment | 3 | 2021 | 3944 | 0.560 |
Why?
|
| Doxorubicin | 2 | 2021 | 2229 | 0.560 |
Why?
|
| Interleukin-6 | 2 | 2021 | 3227 | 0.440 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1559 | 0.400 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2330 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2457 | 0.290 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2061 | 0.280 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2883 | 0.270 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4357 | 0.230 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3582 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 13650 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14476 | 0.110 |
Why?
|
| DNA Damage | 1 | 2021 | 2469 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22361 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3587 | 0.090 |
Why?
|
| Decapodiformes | 1 | 2009 | 38 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1110 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1492 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18330 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8535 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2144 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4648 | 0.070 |
Why?
|
| Symbiosis | 1 | 2009 | 297 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 931 | 0.070 |
Why?
|
| Apoptosis | 1 | 2021 | 9513 | 0.060 |
Why?
|
| Bacterial Toxins | 1 | 2009 | 922 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2016 | 5332 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5389 | 0.050 |
Why?
|
| Mice | 3 | 2021 | 81912 | 0.050 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 1642 | 0.050 |
Why?
|
| Cell Line | 1 | 2016 | 15567 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2010 | 3642 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18989 | 0.040 |
Why?
|
| Animals | 5 | 2021 | 168965 | 0.040 |
Why?
|
| Peptides | 1 | 2010 | 4348 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13491 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2009 | 4925 | 0.030 |
Why?
|
| Humans | 5 | 2022 | 767040 | 0.030 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2010 | 94 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 333 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2012 | 0.020 |
Why?
|
| Cytotoxins | 1 | 2009 | 154 | 0.020 |
Why?
|
| Amidohydrolases | 1 | 2009 | 160 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 810 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2227 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 1376 | 0.020 |
Why?
|
| Mucus | 1 | 2009 | 346 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2415 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2009 | 746 | 0.020 |
Why?
|
| Epithelium | 1 | 2009 | 1606 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1969 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 1429 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2014 | 3076 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3684 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5785 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13411 | 0.010 |
Why?
|
| Cytokines | 1 | 2014 | 7446 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2010 | 4209 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 17608 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81659 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7469 | 0.010 |
Why?
|